Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat (original) (raw)

Hypertension and non-insulin-dependent diabetes

Acta Diabetologica, 1995

Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats

Diabetes, 2013

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial

Bancha Satirapoj

PLOS ONE, 2018

View PDFchevron_right

Pioglitazone Prevents Hypertension and Reduces Oxidative Stress in Diet-Induced Obesity

Ali Khraibi, Anca Dobrian

Hypertension, 2003

View PDFchevron_right

Antihypertensive agents, serum lipoproteins and glucose metabolism

Johan Rosman

The American Journal of Cardiology, 1991

View PDFchevron_right

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes

Supphamat Chirnaksorn

Cureus, 2021

View PDFchevron_right

Population Pharmacokinetics of Pioglitazone in South Indian Type-II Diabetic Patients

Devender Kodati

Asian Journal of Pharmaceutical and Clinical Research, 2014

View PDFchevron_right

Insulin action on heart and skeletal muscle glucose uptake in essential hypertension

Pirjo Nuutila

Journal of Clinical Investigation, 1995

View PDFchevron_right

Comparative evaluation of Pioglitazone versus Voglibose on glycemic control in patients with Type 2 Diabetes Mellitus on Metformin

Mohd Faheem Mubeen

Journal of Medical Science And clinical Research, 2018

View PDFchevron_right

Effect of Pioglitazone and Fluoxetine on Neuropathic Pain Induced Experimentally in Diabetic Rats

Amro El-Karef

View PDFchevron_right

Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease

Georgia Vamvakou

Recent Patents on Cardiovascular Drug Discovery, 2014

View PDFchevron_right

Effect of metformin and Pioglitazone on insulin dose reduction in type 2 diabetes mellitus patients: An open level comparative prospective study

Anindya Dasgupta

Journal of Diabetes Mellitus, 2012

View PDFchevron_right

Central serotonergic participation on blood pressure regulation

Agustín Ramirez

General Pharmacology: The Vascular System, 1982

View PDFchevron_right

Insulin and blood pressure responses to changes in salt intake

Elizabeth Franco jimenez

Journal of Human Hypertension, 2000

View PDFchevron_right

Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice

Natalia Di Pietro

2012

View PDFchevron_right

Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance

Eduardo Hernandez-Salazar

Diabetes Research and Clinical Practice, 2007

View PDFchevron_right

Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin- sensitizing agent pioglitazone

Jerry Colca

Arteriosclerosis, Thrombosis, and Vascular Biology, 1993

View PDFchevron_right

Biochemical alterations and liver toxicity analysis with pioglitazone in healthy subjects

Md. Aftab Uddin

Drug and Chemical Toxicology, 2013

View PDFchevron_right

Increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation impact in metabolic parameters from hypertensive rats

Dora Maria Grassi Kassisse

Endocrine and Metabolic Science, 2021

View PDFchevron_right

Blunted Coronary Vasoreactivity to Insulin Is an Early Alteration in Hypertension

Pirjo Nuutila

Journal of Vascular Research, 2003

View PDFchevron_right

6th Central European Meeting on Hypertension

Renata Cifkova

Kidney and Blood Pressure Research, 2012

View PDFchevron_right

Targeting Hypertension in Patients with Cardiorenal Metabolic Syndrome

valmore bermudez

Current Hypertension Reports, 2012

View PDFchevron_right

Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease

Jackson Wright

2006

View PDFchevron_right

Association of Hypertension and Diabetes with Obesity

Samir Savani

International Journal of Medical and Biomedical Studies, 2020

View PDFchevron_right

Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes

Chrysanthos Zamboulis

Acta Diabetologica, 2008

View PDFchevron_right

Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat (original) (raw)

Related papers